Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients.

Einsiedel L, Cherry CL, Sheeran FL, Friedhuber A, Wesselingh SL, Pepe S.

Mitochondrion. 2010 Aug;10(5):534-9. doi: 10.1016/j.mito.2010.05.010. Epub 2010 May 31.

PMID:
20685321
[PubMed - indexed for MEDLINE]
2.

Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.

Jones SP, Qazi N, Morelese J, Lebrecht D, Sutinen J, Yki-Jărvinen H, Back DJ, Pirmohamed M, Gazzard BG, Walker UA, Moyle GJ.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):565-72.

PMID:
16284533
[PubMed - indexed for MEDLINE]
3.

Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.

Ciccosanti F, Corazzari M, Soldani F, Matarrese P, Pagliarini V, Iadevaia V, Tinari A, Zaccarelli M, Perfettini JL, Malorni W, Kroemer G, Antinori A, Fimia GM, Piacentini M.

Antivir Ther. 2010;15(3):377-90. doi: 10.3851/IMP1530.

PMID:
20516557
[PubMed - indexed for MEDLINE]
4.

Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.

Rosso R, Nasi M, Di Biagio A, Repetto E, Dentone C, Pinti M, Nemes E, Ferraresi R, Mussini C, Esposito R, Viscoli C, Cossarizza A.

Pediatr Infect Dis J. 2008 Jan;27(1):17-21.

PMID:
18162932
[PubMed - indexed for MEDLINE]
5.

Serum L-lactate and pyruvate in HIV-infected patients with and without presumed NRTI-related adverse events compared to healthy volunteers.

ter Hofstede HJ, Willems HL, Koopmans PP.

J Clin Virol. 2004 Jan;29(1):44-50.

PMID:
14675869
[PubMed - indexed for MEDLINE]
6.

Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.

Haugaard SB, Andersen O, Pedersen SB, Dela F, Richelsen B, Nielsen JO, Madsbad S, Iversen J.

J Med Virol. 2005 Sep;77(1):29-38.

PMID:
16032748
[PubMed - indexed for MEDLINE]
7.

Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.

Buffet M, Schwarzinger M, Amellal B, Gourlain K, Bui P, Prévot M, Deleuze J, Morini JP, Gorin I, Calvez V, Dupin N.

J Clin Virol. 2005 May;33(1):60-4.

PMID:
15797366
[PubMed - indexed for MEDLINE]
8.

Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study.

Mussini C, Pinti M, Bugarini R, Borghi V, Nasi M, Nemes E, Troiano L, Guaraldi G, Bedini A, Sabin C, Esposito R, Cossarizza A.

AIDS. 2005 Oct 14;19(15):1627-33.

PMID:
16184032
[PubMed - indexed for MEDLINE]
9.

Increased mitochondrial DNA content in peripheral blood lymphocytes from HIV-infected patients with lipodystrophy.

Cossarizza A, Riva A, Pinti M, Ammannato S, Fedeli P, Mussini C, Esposito R, Galli M.

Antivir Ther. 2003 Aug;8(4):315-21.

PMID:
14518701
[PubMed - indexed for MEDLINE]
10.

Mitochondrial effects of antiretroviral therapies in asymptomatic patients.

López S, Miró O, Martínez E, Pedrol E, Rodríguez-Santiago B, Milinkovic A, Soler A, García-Viejo MA, Nunes V, Casademont J, Gatell JM, Cardellach F.

Antivir Ther. 2004 Feb;9(1):47-55.

PMID:
15040536
[PubMed - indexed for MEDLINE]
11.

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.

Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S.

AIDS. 2003 Jun 13;17(9):1329-38.

PMID:
12799554
[PubMed - indexed for MEDLINE]
12.

[Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].

Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.

Zhonghua Yi Xue Za Zhi. 2007 Nov 13;87(42):2973-6. Chinese.

PMID:
18261327
[PubMed - indexed for MEDLINE]
13.

Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy.

Miró O, López S, Pedrol E, Rodríguez-Santiago B, Martínez E, Soler A, Milinkovic A, Casademont J, Nunes V, Gatell JM, Cardellach F.

Antivir Ther. 2003 Aug;8(4):333-8.

PMID:
14526764
[PubMed - indexed for MEDLINE]
14.

Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.

Casula M, Weverling GJ, Wit FW, Timmermans EC, Stek M Jr, Lange JM, Reiss P.

J Infect Dis. 2005 Nov 15;192(10):1794-800. Epub 2005 Oct 12.

PMID:
16235179
[PubMed - indexed for MEDLINE]
Free Article
15.

Fat distribution and metabolic abnormalities in HIV-infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor.

Domingo P, Sambeat MA, Pérez A, Ordoñez J, Rodriguez J, Vázquez G.

Antivir Ther. 2003 Jun;8(3):223-31.

PMID:
12924539
[PubMed - indexed for MEDLINE]
16.

The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.

Sternfeld T, Schmid M, Tischleder A, Mudra S, Schlamp A, Kost BP, Gruber R, Youle M, Bogner JR, Goebel FD.

Antivir Ther. 2007;12(5):769-78.

PMID:
17713160
[PubMed - indexed for MEDLINE]
17.

Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.

Gingelmaier A, Grubert TA, Kost BP, Setzer B, Lebrecht D, Mylonas I, Mueller-Hoecker J, Jeschke U, Hiedl S, Friese K, Walker UA.

Antivir Ther. 2009;14(3):331-8.

PMID:
19474467
[PubMed - indexed for MEDLINE]
18.

Factors associated with mitochondrial dysfunction in circulating peripheral blood lymphocytes from HIV-infected people.

Polo R, Martinez S, Madrigal P, Gonzalez-Muñoz M.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):32-6.

PMID:
14501790
[PubMed - indexed for MEDLINE]
19.

Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.

Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D.

J Infect Dis. 2008 Nov 15;198(10):1474-81. doi: 10.1086/592713.

PMID:
18851688
[PubMed - indexed for MEDLINE]
Free Article
20.

Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.

Gerschenson M, Kim C, Berzins B, Taiwo B, Libutti DE, Choi J, Chen D, Weinstein J, Shore J, da Silva B, Belsey E, McComsey GA, Murphy RL.

J Antimicrob Chemother. 2009 Jun;63(6):1244-50. doi: 10.1093/jac/dkp100. Epub 2009 Mar 25.

PMID:
19321503
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk